Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Buy
62
UPGD Quote, Financials, Valuation and Earnings
Last price:
$78.99
Seasonality move
:
2.81%
Day range:
$79.08 - $79.27
52-week range:
$61.76 - $79.30
Dividend yield:
1.63%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
13K
Avg. volume:
2.3K
1-year change:
9.43%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
UPGD
Invesco Bloomberg Analyst Rating Improvers ETF
|
-- | -- | -- | -- | -- |
|
CZA
Invesco Zacks Mid-Cap ETF
|
-- | -- | -- | -- | -- |
|
IQSM
NYLI Candriam US Mid Cap Equity ETF
|
-- | -- | -- | -- | -- |
|
IWR
iShares Russell Mid-Cap ETF
|
-- | -- | -- | -- | -- |
|
JHMM
John Hancock Multifactor Mid Cap ETF
|
-- | -- | -- | -- | -- |
|
JPME
JPMorgan Diversified Return US Mid Cap Equity ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
UPGD
Invesco Bloomberg Analyst Rating Improvers ETF
|
$79.22 | -- | -- | -- | $1.29 | 1.63% | -- |
|
CZA
Invesco Zacks Mid-Cap ETF
|
$117.05 | -- | -- | -- | $1.73 | 1.47% | -- |
|
IQSM
NYLI Candriam US Mid Cap Equity ETF
|
$36.94 | -- | -- | -- | $0.13 | 1.1% | -- |
|
IWR
iShares Russell Mid-Cap ETF
|
$102.17 | -- | -- | -- | $0.39 | 1.21% | -- |
|
JHMM
John Hancock Multifactor Mid Cap ETF
|
$70.92 | -- | -- | -- | $0.37 | 0.9% | -- |
|
JPME
JPMorgan Diversified Return US Mid Cap Equity ETF
|
$118.73 | -- | -- | -- | $0.73 | 1.86% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
UPGD
Invesco Bloomberg Analyst Rating Improvers ETF
|
-- | 0.445 | -- | -- |
|
CZA
Invesco Zacks Mid-Cap ETF
|
-- | 0.496 | -- | -- |
|
IQSM
NYLI Candriam US Mid Cap Equity ETF
|
-- | 0.878 | -- | -- |
|
IWR
iShares Russell Mid-Cap ETF
|
-- | 0.811 | -- | -- |
|
JHMM
John Hancock Multifactor Mid Cap ETF
|
-- | 0.856 | -- | -- |
|
JPME
JPMorgan Diversified Return US Mid Cap Equity ETF
|
-- | 0.530 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
UPGD
Invesco Bloomberg Analyst Rating Improvers ETF
|
-- | -- | -- | -- | -- | -- |
|
CZA
Invesco Zacks Mid-Cap ETF
|
-- | -- | -- | -- | -- | -- |
|
IQSM
NYLI Candriam US Mid Cap Equity ETF
|
-- | -- | -- | -- | -- | -- |
|
IWR
iShares Russell Mid-Cap ETF
|
-- | -- | -- | -- | -- | -- |
|
JHMM
John Hancock Multifactor Mid Cap ETF
|
-- | -- | -- | -- | -- | -- |
|
JPME
JPMorgan Diversified Return US Mid Cap Equity ETF
|
-- | -- | -- | -- | -- | -- |
Invesco Bloomberg Analyst Rating Improvers ETF vs. Competitors
-
Which has Higher Returns UPGD or CZA?
Invesco Zacks Mid-Cap ETF has a net margin of -- compared to Invesco Bloomberg Analyst Rating Improvers ETF's net margin of --. Invesco Bloomberg Analyst Rating Improvers ETF's return on equity of -- beat Invesco Zacks Mid-Cap ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital UPGDInvesco Bloomberg Analyst Rating Improvers ETF-- -- -- CZAInvesco Zacks Mid-Cap ETF-- -- -- -
What do Analysts Say About UPGD or CZA?
Invesco Bloomberg Analyst Rating Improvers ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco Zacks Mid-Cap ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco Bloomberg Analyst Rating Improvers ETF has higher upside potential than Invesco Zacks Mid-Cap ETF, analysts believe Invesco Bloomberg Analyst Rating Improvers ETF is more attractive than Invesco Zacks Mid-Cap ETF.
Company Buy Ratings Hold Ratings Sell Ratings UPGDInvesco Bloomberg Analyst Rating Improvers ETF0 0 0 CZAInvesco Zacks Mid-Cap ETF0 0 0 -
Is UPGD or CZA More Risky?
Invesco Bloomberg Analyst Rating Improvers ETF has a beta of 0.941, which suggesting that the stock is 5.91% less volatile than S&P 500. In comparison Invesco Zacks Mid-Cap ETF has a beta of 0.878, suggesting its less volatile than the S&P 500 by 12.207%.
-
Which is a Better Dividend Stock UPGD or CZA?
Invesco Bloomberg Analyst Rating Improvers ETF has a quarterly dividend of $1.29 per share corresponding to a yield of 1.63%. Invesco Zacks Mid-Cap ETF offers a yield of 1.47% to investors and pays a quarterly dividend of $1.73 per share. Invesco Bloomberg Analyst Rating Improvers ETF pays -- of its earnings as a dividend. Invesco Zacks Mid-Cap ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios UPGD or CZA?
Invesco Bloomberg Analyst Rating Improvers ETF quarterly revenues are --, which are smaller than Invesco Zacks Mid-Cap ETF quarterly revenues of --. Invesco Bloomberg Analyst Rating Improvers ETF's net income of -- is lower than Invesco Zacks Mid-Cap ETF's net income of --. Notably, Invesco Bloomberg Analyst Rating Improvers ETF's price-to-earnings ratio is -- while Invesco Zacks Mid-Cap ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco Bloomberg Analyst Rating Improvers ETF is -- versus -- for Invesco Zacks Mid-Cap ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income UPGDInvesco Bloomberg Analyst Rating Improvers ETF-- -- -- -- CZAInvesco Zacks Mid-Cap ETF-- -- -- --
-
Which has Higher Returns UPGD or IQSM?
NYLI Candriam US Mid Cap Equity ETF has a net margin of -- compared to Invesco Bloomberg Analyst Rating Improvers ETF's net margin of --. Invesco Bloomberg Analyst Rating Improvers ETF's return on equity of -- beat NYLI Candriam US Mid Cap Equity ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital UPGDInvesco Bloomberg Analyst Rating Improvers ETF-- -- -- IQSMNYLI Candriam US Mid Cap Equity ETF-- -- -- -
What do Analysts Say About UPGD or IQSM?
Invesco Bloomberg Analyst Rating Improvers ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand NYLI Candriam US Mid Cap Equity ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco Bloomberg Analyst Rating Improvers ETF has higher upside potential than NYLI Candriam US Mid Cap Equity ETF, analysts believe Invesco Bloomberg Analyst Rating Improvers ETF is more attractive than NYLI Candriam US Mid Cap Equity ETF.
Company Buy Ratings Hold Ratings Sell Ratings UPGDInvesco Bloomberg Analyst Rating Improvers ETF0 0 0 IQSMNYLI Candriam US Mid Cap Equity ETF0 0 0 -
Is UPGD or IQSM More Risky?
Invesco Bloomberg Analyst Rating Improvers ETF has a beta of 0.941, which suggesting that the stock is 5.91% less volatile than S&P 500. In comparison NYLI Candriam US Mid Cap Equity ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock UPGD or IQSM?
Invesco Bloomberg Analyst Rating Improvers ETF has a quarterly dividend of $1.29 per share corresponding to a yield of 1.63%. NYLI Candriam US Mid Cap Equity ETF offers a yield of 1.1% to investors and pays a quarterly dividend of $0.13 per share. Invesco Bloomberg Analyst Rating Improvers ETF pays -- of its earnings as a dividend. NYLI Candriam US Mid Cap Equity ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios UPGD or IQSM?
Invesco Bloomberg Analyst Rating Improvers ETF quarterly revenues are --, which are smaller than NYLI Candriam US Mid Cap Equity ETF quarterly revenues of --. Invesco Bloomberg Analyst Rating Improvers ETF's net income of -- is lower than NYLI Candriam US Mid Cap Equity ETF's net income of --. Notably, Invesco Bloomberg Analyst Rating Improvers ETF's price-to-earnings ratio is -- while NYLI Candriam US Mid Cap Equity ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco Bloomberg Analyst Rating Improvers ETF is -- versus -- for NYLI Candriam US Mid Cap Equity ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income UPGDInvesco Bloomberg Analyst Rating Improvers ETF-- -- -- -- IQSMNYLI Candriam US Mid Cap Equity ETF-- -- -- --
-
Which has Higher Returns UPGD or IWR?
iShares Russell Mid-Cap ETF has a net margin of -- compared to Invesco Bloomberg Analyst Rating Improvers ETF's net margin of --. Invesco Bloomberg Analyst Rating Improvers ETF's return on equity of -- beat iShares Russell Mid-Cap ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital UPGDInvesco Bloomberg Analyst Rating Improvers ETF-- -- -- IWRiShares Russell Mid-Cap ETF-- -- -- -
What do Analysts Say About UPGD or IWR?
Invesco Bloomberg Analyst Rating Improvers ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares Russell Mid-Cap ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco Bloomberg Analyst Rating Improvers ETF has higher upside potential than iShares Russell Mid-Cap ETF, analysts believe Invesco Bloomberg Analyst Rating Improvers ETF is more attractive than iShares Russell Mid-Cap ETF.
Company Buy Ratings Hold Ratings Sell Ratings UPGDInvesco Bloomberg Analyst Rating Improvers ETF0 0 0 IWRiShares Russell Mid-Cap ETF0 0 0 -
Is UPGD or IWR More Risky?
Invesco Bloomberg Analyst Rating Improvers ETF has a beta of 0.941, which suggesting that the stock is 5.91% less volatile than S&P 500. In comparison iShares Russell Mid-Cap ETF has a beta of 1.044, suggesting its more volatile than the S&P 500 by 4.417%.
-
Which is a Better Dividend Stock UPGD or IWR?
Invesco Bloomberg Analyst Rating Improvers ETF has a quarterly dividend of $1.29 per share corresponding to a yield of 1.63%. iShares Russell Mid-Cap ETF offers a yield of 1.21% to investors and pays a quarterly dividend of $0.39 per share. Invesco Bloomberg Analyst Rating Improvers ETF pays -- of its earnings as a dividend. iShares Russell Mid-Cap ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios UPGD or IWR?
Invesco Bloomberg Analyst Rating Improvers ETF quarterly revenues are --, which are smaller than iShares Russell Mid-Cap ETF quarterly revenues of --. Invesco Bloomberg Analyst Rating Improvers ETF's net income of -- is lower than iShares Russell Mid-Cap ETF's net income of --. Notably, Invesco Bloomberg Analyst Rating Improvers ETF's price-to-earnings ratio is -- while iShares Russell Mid-Cap ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco Bloomberg Analyst Rating Improvers ETF is -- versus -- for iShares Russell Mid-Cap ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income UPGDInvesco Bloomberg Analyst Rating Improvers ETF-- -- -- -- IWRiShares Russell Mid-Cap ETF-- -- -- --
-
Which has Higher Returns UPGD or JHMM?
John Hancock Multifactor Mid Cap ETF has a net margin of -- compared to Invesco Bloomberg Analyst Rating Improvers ETF's net margin of --. Invesco Bloomberg Analyst Rating Improvers ETF's return on equity of -- beat John Hancock Multifactor Mid Cap ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital UPGDInvesco Bloomberg Analyst Rating Improvers ETF-- -- -- JHMMJohn Hancock Multifactor Mid Cap ETF-- -- -- -
What do Analysts Say About UPGD or JHMM?
Invesco Bloomberg Analyst Rating Improvers ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand John Hancock Multifactor Mid Cap ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco Bloomberg Analyst Rating Improvers ETF has higher upside potential than John Hancock Multifactor Mid Cap ETF, analysts believe Invesco Bloomberg Analyst Rating Improvers ETF is more attractive than John Hancock Multifactor Mid Cap ETF.
Company Buy Ratings Hold Ratings Sell Ratings UPGDInvesco Bloomberg Analyst Rating Improvers ETF0 0 0 JHMMJohn Hancock Multifactor Mid Cap ETF0 0 0 -
Is UPGD or JHMM More Risky?
Invesco Bloomberg Analyst Rating Improvers ETF has a beta of 0.941, which suggesting that the stock is 5.91% less volatile than S&P 500. In comparison John Hancock Multifactor Mid Cap ETF has a beta of 1.035, suggesting its more volatile than the S&P 500 by 3.527%.
-
Which is a Better Dividend Stock UPGD or JHMM?
Invesco Bloomberg Analyst Rating Improvers ETF has a quarterly dividend of $1.29 per share corresponding to a yield of 1.63%. John Hancock Multifactor Mid Cap ETF offers a yield of 0.9% to investors and pays a quarterly dividend of $0.37 per share. Invesco Bloomberg Analyst Rating Improvers ETF pays -- of its earnings as a dividend. John Hancock Multifactor Mid Cap ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios UPGD or JHMM?
Invesco Bloomberg Analyst Rating Improvers ETF quarterly revenues are --, which are smaller than John Hancock Multifactor Mid Cap ETF quarterly revenues of --. Invesco Bloomberg Analyst Rating Improvers ETF's net income of -- is lower than John Hancock Multifactor Mid Cap ETF's net income of --. Notably, Invesco Bloomberg Analyst Rating Improvers ETF's price-to-earnings ratio is -- while John Hancock Multifactor Mid Cap ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco Bloomberg Analyst Rating Improvers ETF is -- versus -- for John Hancock Multifactor Mid Cap ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income UPGDInvesco Bloomberg Analyst Rating Improvers ETF-- -- -- -- JHMMJohn Hancock Multifactor Mid Cap ETF-- -- -- --
-
Which has Higher Returns UPGD or JPME?
JPMorgan Diversified Return US Mid Cap Equity ETF has a net margin of -- compared to Invesco Bloomberg Analyst Rating Improvers ETF's net margin of --. Invesco Bloomberg Analyst Rating Improvers ETF's return on equity of -- beat JPMorgan Diversified Return US Mid Cap Equity ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital UPGDInvesco Bloomberg Analyst Rating Improvers ETF-- -- -- JPMEJPMorgan Diversified Return US Mid Cap Equity ETF-- -- -- -
What do Analysts Say About UPGD or JPME?
Invesco Bloomberg Analyst Rating Improvers ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand JPMorgan Diversified Return US Mid Cap Equity ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco Bloomberg Analyst Rating Improvers ETF has higher upside potential than JPMorgan Diversified Return US Mid Cap Equity ETF, analysts believe Invesco Bloomberg Analyst Rating Improvers ETF is more attractive than JPMorgan Diversified Return US Mid Cap Equity ETF.
Company Buy Ratings Hold Ratings Sell Ratings UPGDInvesco Bloomberg Analyst Rating Improvers ETF0 0 0 JPMEJPMorgan Diversified Return US Mid Cap Equity ETF0 0 0 -
Is UPGD or JPME More Risky?
Invesco Bloomberg Analyst Rating Improvers ETF has a beta of 0.941, which suggesting that the stock is 5.91% less volatile than S&P 500. In comparison JPMorgan Diversified Return US Mid Cap Equity ETF has a beta of 0.946, suggesting its less volatile than the S&P 500 by 5.398%.
-
Which is a Better Dividend Stock UPGD or JPME?
Invesco Bloomberg Analyst Rating Improvers ETF has a quarterly dividend of $1.29 per share corresponding to a yield of 1.63%. JPMorgan Diversified Return US Mid Cap Equity ETF offers a yield of 1.86% to investors and pays a quarterly dividend of $0.73 per share. Invesco Bloomberg Analyst Rating Improvers ETF pays -- of its earnings as a dividend. JPMorgan Diversified Return US Mid Cap Equity ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios UPGD or JPME?
Invesco Bloomberg Analyst Rating Improvers ETF quarterly revenues are --, which are smaller than JPMorgan Diversified Return US Mid Cap Equity ETF quarterly revenues of --. Invesco Bloomberg Analyst Rating Improvers ETF's net income of -- is lower than JPMorgan Diversified Return US Mid Cap Equity ETF's net income of --. Notably, Invesco Bloomberg Analyst Rating Improvers ETF's price-to-earnings ratio is -- while JPMorgan Diversified Return US Mid Cap Equity ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco Bloomberg Analyst Rating Improvers ETF is -- versus -- for JPMorgan Diversified Return US Mid Cap Equity ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income UPGDInvesco Bloomberg Analyst Rating Improvers ETF-- -- -- -- JPMEJPMorgan Diversified Return US Mid Cap Equity ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
58
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Sell
40
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 29x
Alerts
Buy
91
TDC alert for Feb 12
Teradata Corp. [TDC] is down 10.67% over the past day.
Buy
67
DIOD alert for Feb 12
Diodes, Inc. [DIOD] is down 7.04% over the past day.
Buy
77
VRT alert for Feb 12
Vertiv Holdings Co. [VRT] is down 4.72% over the past day.
